--- title: "Clover Biopharmaceuticals (2197) stock and investor profile" url: "https://aibio.space/companies/clover-biopharmaceuticals/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Clover Biopharmaceuticals Ltd. (HKEX: 2197), China. The directory classifies it as Pharmaceuticals: Major." --- 2197 Clover Biopharmaceuticals Ltd. HKEX · China # Clover Biopharmaceuticals (2197) news Clover Biopharmaceuticals Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 2197, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Clover Biopharmaceuticals news We have not published a story on Clover Biopharmaceuticals yet. When there is news, it will appear here. ## Clover Biopharmaceuticals at a glance - **Ticker**: 2197 - **Listing**: HKEX - **Country**: China ### Related companies - [Xiamen Kingdomway Group Co.](https://aibio.space/companies/xiamen-kingdomway/) SZSE: 002626 - [Kingchem (Liaoning) Life Science Co.](https://aibio.space/companies/kingchem-liaoning-life-science/) SZSE: 301509 - [Cachet Pharmaceutical Co.](https://aibio.space/companies/cachet-pharmaceutical/) SZSE: 002462 - [Tasly Pharmaceutical Group Co.](https://aibio.space/companies/tasly-pharmaceutical/) SSE: 600535 - [Zhangzhou Pientzehuang Pharmaceutical Co.](https://aibio.space/companies/zhangzhou-pientzehuang-pharmaceutical/) SSE: 600436 - [Beijing Science Sun Pharmaceutical Co.](https://aibio.space/companies/beijing-science-sun-pharmaceutical/) SZSE: 300485 - [Shenzhen Hepalink Pharmaceutical Group Co.](https://aibio.space/companies/shenzhen-hepalink-pharmaceutical/) SZSE: 002399 - [Hanshang Group Co.](https://aibio.space/companies/hanshang/) SSE: 600774 ### Also on HKEX - [Wuxi Biologics (Cayman)](https://aibio.space/companies/wuxi-biologics-cayman/) 2269 - [JW (Cayman) Therapeutics Co.](https://aibio.space/companies/jw-cayman-therapeutics/) 2126 - [Tong Ren Tang Technologies Co.](https://aibio.space/companies/tong-ren-tang-technologies/) 1666 - [Genscript Biotech](https://aibio.space/companies/genscript-biotech/) 1548 - [Cutia Therapeutics](https://aibio.space/companies/cutia-therapeutics/) 2487 - [CStone Pharmaceuticals](https://aibio.space/companies/cstone-pharmaceuticals/) 2616 ## Questions about Clover Biopharmaceuticals What is the ticker symbol of Clover Biopharmaceuticals? Clover Biopharmaceuticals Ltd. trades under the ticker 2197 on HKEX. Where is Clover Biopharmaceuticals listed? Clover Biopharmaceuticals Ltd. is listed on HKEX. Which country or territory is Clover Biopharmaceuticals listed under? Our directory records Clover Biopharmaceuticals Ltd. under China. What does Clover Biopharmaceuticals do? Our directory classifies Clover Biopharmaceuticals Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline. What is the ISIN of Clover Biopharmaceuticals? The ISIN recorded for Clover Biopharmaceuticals Ltd. is KYG2280A1076. Does aibio.space cover Clover Biopharmaceuticals? aibio.space lists Clover Biopharmaceuticals Ltd. among 2,820 public biotech companies and publishes its news here as stories appear. Which companies are similar to Clover Biopharmaceuticals? Companies in our directory listed in the same country and business area as Clover Biopharmaceuticals: Xiamen Kingdomway Group Co., Kingchem (Liaoning) Life Science Co., Cachet Pharmaceutical Co., Tasly Pharmaceutical Group Co., Zhangzhou Pientzehuang Pharmaceutical Co., Beijing Science Sun Pharmaceutical Co.. ## Investor discussion: Clover Biopharmaceuticals Members talk about Clover Biopharmaceuticals (2197). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Clover Biopharmaceuticals, newest first. Each line links the filing it comes from. 1. 2026-05-26 Financings Share or debt issue: (1). PROPOSED GRANT OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES AND/OR SELL OR TRANSFER TREASURY SHARES; (2). PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS; (3). PROPOSED RE-APPOINTMENT OF AUDITOR; (4). PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION; AND (5). NOTICE OF ANNUAL GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0526/2026052600662.pdf) 2. 2025-05-21 Financings Share or debt issue: (1). PROPOSED GRANT OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES AND/OR SELL OR TRANSFER TREASURY SHARES; (2). PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS; (3). PROPOSED APPOINTMENT OF AUDITOR; AND (4). NOTICE OF ANNUAL GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0521/2025052100257.pdf) ## Press releases Headlines of Clover Biopharmaceuticals's own announcements, newest first. Each opens the full release on the newswire that carried it. 1. 2026-09-06 HKEXnews [Voluntary Announcement Clover Announces Positive Australia Phase 2 Clinical Data for RSV + hMPV + PIV3 Respiratory Combination Vaccine Candidates in Older Adults](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0907/2026090700013.pdf) 2. 2026-08-25 HKEXnews [INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0826/2026082600005.pdf) 3. 2026-07-19 HKEXnews [POSITIVE PROFIT ALERT](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0720/2026072000027.pdf) 4. 2026-06-18 HKEXnews [SIXTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0618/2026061801996.pdf) 5. 2026-06-18 HKEXnews [POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 18, 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0618/2026061801924.pdf) 6. 2026-06-05 HKEXnews [SUPPLEMENTAL ANNOUNCEMENT](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0605/2026060501572.pdf) 7. 2026-05-26 HKEXnews [NOTICE OF ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0526/2026052600666.pdf) 8. 2026-05-26 HKEXnews [(1). PROPOSED GRANT OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES AND/OR SELL OR TRANSFER TREASURY SHARES; (2). PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS; (3). PROPOSED RE-APPOINTMENT OF AUDITOR; (4). PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION; AND (5). NOTICE OF ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0526/2026052600662.pdf) 9. 2026-04-23 HKEXnews [Letter to Non-Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications and Reply Form](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0423/2026042301998.pdf) 10. 2026-04-23 HKEXnews [Letter to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications and Reply Form](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0423/2026042301982.pdf) 11. 2026-04-02 HKEXnews [SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO INSIDE INFORMATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0402/2026040202068.pdf) 12. 2026-03-29 HKEXnews [Voluntary Announcement Clover Completes Enrollment in Australian Phase 2 Clinical Trial for RSV + hMPV + PIV3 Respiratory Combination Vaccine Candidates](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0330/2026033000009.pdf) 13. 2026-03-27 HKEXnews [GRANT OF OPTIONS PURSUANT TO THE POST-IPO SHARE OPTION PLAN AND GRANT OF RSUs PURSUANT TO THE RSU SCHEME](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0327/2026032702498.pdf) 14. 2026-03-25 HKEXnews [ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025 AND PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0326/2026032600025.pdf) 15. 2026-03-24 HKEXnews [VOLUNTARY ANNOUNCEMENT CLOVER ANNOUNCES ADDITIONAL POSITIVE U.S. PHASE I CLINICAL DATA FOR RSV RE-VACCINATION IN OLDER ADULTS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0325/2026032500105.pdf) 16. 2026-03-22 HKEXnews [INSIDE INFORMATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0322/2026032200151.pdf) 17. 2026-01-12 HKEXnews [VOLUNTARY ANNOUNCEMENT CLOVER INITIATES PHASE 2 CLINICAL TRIAL FOR RSV - HMPV - PIV3 RESPIRATORY COMBINATION VACCINE CANDIDATES](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0112/2026011200195.pdf) 18. 2025-10-14 HKEXnews [VOLUNTARY ANNOUNCEMENT - CLOVER ANNOUNCES POSITIVE PHASE I CLINICAL DATA FOR RSV-HMPV-PIV3 COMBINATION VACCINES AND FOR RSV RE-VACCINATION IN OLDER ADULTS](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1014/2025101400766.pdf) 19. 2025-08-26 HKEXnews [INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0827/2025082700143.pdf) 20. 2025-07-02 HKEXnews [Nomination Committee - Terms of Reference](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0702/2025070203941.pdf) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open HKEX:2197 on TradingView](https://www.tradingview.com/symbols/HKEX-2197/). ## Listing details Clover Biopharmaceuticals Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 2197, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Clover Biopharmaceuticals Ltd. - **Ticker**: 2197 - **Listing**: HKEX - **Country or territory**: China - **Business scope**: Pharmaceuticals: Major - **ISIN**: KYG2280A1076 - **Last quote in directory**: 2026-10-22 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/HKEX-2197/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/clover-biopharmaceuticals/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Clover Biopharmaceuticals (2197) stock and investor profile", 2026-10-31, https://aibio.space/companies/clover-biopharmaceuticals/